Paul Bigliardi Selected Research

Paul Bigliardi Research Topics

2	Hypersensitivity (Allergy) 01/2019 - 01/2017
1	Neoplasms (Cancer) 01/2024
1	Lichen Planus (Lichen Ruber Planus) 11/2023
1	Allergic Contact Dermatitis 01/2021
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2019
1	Sensation Disorders 01/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Infections 12/2014
1	Chronic Urticaria 11/2012
1	Colitis 11/2012
1	Cardiomyopathies (Cardiomyopathy) 11/2012
1	Sunburn 11/2012
1	Pain (Aches) 03/2011
1	Inflammation (Inflammations) 03/2011
1	Edema (Dropsy) 03/2011

1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 11/2023
1	Tuberculin (PPD)IBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 01/2019
1	abacavir (Ziagen)FDA Link 01/2019
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2019
1	HLA-B57 antigenIBA 01/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2017
1	Povidone-Iodine (Betadine)FDA LinkGeneric 01/2017
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2014
1	CaspasesIBA 11/2012
1	AnticoagulantsIBA 11/2012
1	Phosphotransferases (Kinase)IBA 11/2012
1	TachykininsIBA 03/2011
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2011
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 03/2011
1	Substance PIBA 03/2011

1	Intradermal Injections 03/2011